» Articles » PMID: 20007717

Molecular Characterization of the Interaction of Staphylococcal Microbial Surface Components Recognizing Adhesive Matrix Molecules (MSCRAMM) ClfA and Fbl with Fibrinogen

Overview
Journal J Biol Chem
Specialty Biochemistry
Date 2009 Dec 17
PMID 20007717
Citations 41
Authors
Affiliations
Soon will be listed here.
Abstract

The ligand-binding domain of Fbl (the fibrinogen binding protein from Staphylococcus lugdunensis) shares 60% sequence identity with ClfA (clumping factor A) of Staphylococcus aureus. Recombinant Fbl corresponding to the minimum fibrinogen-binding region (subdomains N2N3) was compared with ClfA for binding to fibrinogen. Fbl and ClfA had very similar affinities for fibrinogen by surface plasmon resonance. The binding site for Fbl in fibrinogen was localized to the extreme C terminus of the fibrinogen gamma-chain at the same site recognized by ClfA. Isothermal titration calorimetry showed that Fbl and ClfA had very similar affinities for a peptide mimicking the C-terminal segment of the fibrinogen gamma-chain. The peptide also inhibited binding of Fbl and ClfA to fibrinogen. A series of substituted gamma-chain variant peptides behaved very similarly when used to inhibit ClfA and Fbl binding to immobilized fibrinogen. Both ClfA and Fbl bound to bovine fibrinogen with a lower affinity compared with human fibrinogen and did not bind detectably to ovine fibrinogen. The structure of the N2N3 subdomains of Fbl in complex with the fibrinogen gamma-chain peptide was modeled based on the crystal structure of the N2N3 subdomains of the ClfA-gamma-chain peptide complex. Residues in the putative binding trench likely to be involved in fibrinogen binding were identified. Fbl variant proteins with alanine substitutions in key residues had reduced affinities for fibrinogen. Thus Fbl and ClfA bind the same site in fibrinogen by similar mechanisms.

Citing Articles

IL-10 inhibition during immunization improves vaccine-induced protection against Staphylococcus aureus infection.

Kelly A, McCarthy K, Claxton T, Carlile S, OBrien E, Vozza E JCI Insight. 2024; 9(13).

PMID: 38973612 PMC: 11383370. DOI: 10.1172/jci.insight.178216.


Peritoneal Dialysis-Related Peritonitis: A Matched Comparative Analysis.

Fung W, Sze R, Szeto C, Chow K Kidney Med. 2024; 6(5):100811.

PMID: 38650953 PMC: 11033185. DOI: 10.1016/j.xkme.2024.100811.


Searching for Virulence Factors among Isolates from Orthopedic Infections: Correlation of , and Genes with Hemolytic Activity and Synergistic Hemolytic Activity.

Ravaioli S, Campoccia D, Mirzaei R, Mariani V, Bottau G, De Donno A Int J Mol Sci. 2023; 24(21).

PMID: 37958706 PMC: 10650139. DOI: 10.3390/ijms242115724.


Surviving a sticky situation: therapeutic administration of fibrinogen variant γ' improves outcomes of Staphylococcus aureus septicemia.

Ariens R, Cassat J J Thromb Haemost. 2023; 21(8):2048-2050.

PMID: 37468174 PMC: 10947783. DOI: 10.1016/j.jtha.2023.04.013.


Fibrinogen γ' promotes host survival during Staphylococcus aureus septicemia in mice.

Negron O, Weggeman M, Grimbergen J, Clark E, Abrahams S, Hur W J Thromb Haemost. 2023; 21(8):2277-2290.

PMID: 37001817 PMC: 10528022. DOI: 10.1016/j.jtha.2023.03.019.


References
1.
Ganesh V, Rivera J, Smeds E, Ko Y, Bowden M, Wann E . A structural model of the Staphylococcus aureus ClfA-fibrinogen interaction opens new avenues for the design of anti-staphylococcal therapeutics. PLoS Pathog. 2008; 4(11):e1000226. PMC: 2582960. DOI: 10.1371/journal.ppat.1000226. View

2.
Keane F, Loughman A, Valtulina V, Brennan M, Speziale P, Foster T . Fibrinogen and elastin bind to the same region within the A domain of fibronectin binding protein A, an MSCRAMM of Staphylococcus aureus. Mol Microbiol. 2007; 63(3):711-23. DOI: 10.1111/j.1365-2958.2006.05552.x. View

3.
McDevitt D, Francois P, Vaudaux P, Foster T . Identification of the ligand-binding domain of the surface-located fibrinogen receptor (clumping factor) of Staphylococcus aureus. Mol Microbiol. 1995; 16(5):895-907. DOI: 10.1111/j.1365-2958.1995.tb02316.x. View

4.
OConnell D, Nanavaty T, McDevitt D, Gurusiddappa S, Hook M, Foster T . The fibrinogen-binding MSCRAMM (clumping factor) of Staphylococcus aureus has a Ca2+-dependent inhibitory site. J Biol Chem. 1998; 273(12):6821-9. DOI: 10.1074/jbc.273.12.6821. View

5.
Hall A, Domanski P, Patel P, Vernachio J, Syribeys P, Gorovits E . Characterization of a protective monoclonal antibody recognizing Staphylococcus aureus MSCRAMM protein clumping factor A. Infect Immun. 2003; 71(12):6864-70. PMC: 308922. DOI: 10.1128/IAI.71.12.6864-6870.2003. View